Thomas Edward Hamilton's most recent trade in Larimar Therapeutics Inc was a trade of 50,000 Common Stock done at an average price of $3.3 . Disclosure was reported to the exchange on July 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Purchase of securities on an exchange or from another person at price $ 3.34 per share. | 06 Jul 2026 | 50,000 | 714,798 | - | 3.3 | 166,890 | Common Stock |
| Annaly Cap Management Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 8,641 | 53,884 | - | - | Deferred Stock Units | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2026 | 55,150 | 55,150 | - | - | Stock Option (Right to Buy) | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 27 Feb 2026 | 100,000 | 664,798 | - | 5 | 500,000 | Common Stock |
| Annaly Cap Management Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 8,961 | 45,243 | - | - | Deferred Stock Units | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2025 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Annaly Cap Management Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 8,583 | 36,282 | - | - | Deferred Stock Units | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Purchase of securities on an exchange or from another person at price $ 8.74 per share. | 16 Feb 2024 | 57,208 | 564,798 | - | 8.7 | 499,998 | Common Stock |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 19,000 | 19,000 | - | - | Stock Option (Right to Buy) | |
| Annaly Cap Management Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 8,167 | 27,698 | - | - | Deferred Stock Units | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 8,300 | 8,300 | - | - | Stock Option (Right to Buy) | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Purchase of securities on an exchange or from another person at price $ 3.15 per share. | 16 Sep 2022 | 317,460 | 507,590 | - | 3.2 | 999,999 | Common Stock |
| Annaly Cap Management Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 24,372 | 78,124 | - | - | Deferred Stock Units | |
| Larimar Therapeutics Inc | Thomas Edward Hamilton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 8,300 | 8,300 | - | - | Stock Option (Right to Buy) |